Skip to main content
Log in

Adult patients with tetanus in Slovenia 2006–2021

Results of a national cohort study

  • original article
  • Published:
Wiener klinische Wochenschrift Aims and scope Submit manuscript

Summary

Introduction

The aim of the present study was to determine the demographic, epidemiological and clinical characteristics of adult patients with tetanus in Slovenia between 2006 and 2021, as well as to determine the therapeutic approaches which have been successfully used in the intensive care unit (ICU) of the Infectious Diseases Department in the University Medical Centre Ljubljana (UMC).

Methods

We included all adult patients who were treated for tetanus in the ICU of the Department of Infectious Diseases Ljubljana between January 1st, 2006, and December 31th, 2021, in the retrospective study. Available epidemiological and clinical characteristics were reviewed from the medical documentation.

Results

There were 31 patients included in the study, four (12.9%) males and 27 (87.1%) females. The vast majority of patients required mechanical ventilation (MV) (87.1%) which lasted (± SD) on average 35.4 ± 16.0 days. Autonomic dysfunction was present in 29 (93.5%) patients and was statistically significantly associated with shorter disease evolution (p = 0.005) and presence of healthcare-associated infection (p = 0.020). During the hospitalization, 27 (87.1%) patients acquired at least one healthcare-associated infection, most commonly ventilator-associated pneumonia. The average length of stay in the ICU (± SD) was 42.5 ± 21.3 days. With increasing age, MV lasted statistically significantly longer (p = 0.001), length of stay was longer (p = 0.015), and healthcare-associated infections occurred (p = 0.003) more frequently. Four patients (12.9%) died.

Conclusions

Although the tetanus incidence rate in Slovenia is high in comparison to other European countries on average, our therapeutic approach resulted in a good survival rate and low mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bae C, Bourget D. Tetanus. https://www.ncbi.nlm.nih.gov/books/NBK459217/. Accessed 17 Oct 2022.

  2. WHO. Tetanus reported cases. https://immunizationdata.who.int/pages/incidence/TTETANUS.html?CODE=Global&DISEASE=TTETANUS&YEAR=. Accessed 17 Oct 2022.

  3. WHO. Immunization coverage. https://www.who.int/data/gho/data/themes/topics/immunization-coverage. Accessed 17 Oct 2022.

  4. WHO. Maternal and neonatal tetanus elimination. https://www.who.int/initiatives/maternal-and-neonatal-tetanus-elimination-(mnte)/progress-towards-global-mnt-elimination. Accessed 17 Oct 2022.

  5. CDC. Manual for the surveillance of vaccine-preventable diseases. Chapter 16: Tetanus. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt16-tetanus.html. Accessed 17 Oct 2022.

  6. Gilligan JEF, Lawrence JR, Clayton D, Rowland R. Tetanus and the evolution of intensive care in Australia. Crit Care J Aust Acad Crist Care Med. 2012;14:316–23.

    Google Scholar 

  7. Kyu HH, Mumford JE, Stanaway JD, Barber RM, Hancock JR, Vos T, et al. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health. 2017;17:179–96.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.

    Article  PubMed  Google Scholar 

  9. ECDC. Tetanus—annual epidemiological report for 2018. https://www.ecdc.europa.eu/sites/default/files/documents/Tetanus_AER_2018_Report.pdf. Accessed 17 Oct 2022.

  10. NIJZ. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 2019 in 2020. https://www.nijz.si/sites/www.nijz.si/files/uploaded/epidemiolosko_spremljanje_nalezljivih_bolezni_v_sloveniji_v_letu_2019_in_2020_0.pdf. Accessed 17 Oct 2022.

  11. NIJZ. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 2018. https://www.nijz.si/sites/www.nijz.si/files/uploaded/epidemiolosko_spremljanje_nalezljivih_bolezni_v_sloveniji_v_letu_2018.pdf. Accessed 17 Oct 2022.

  12. NIJZ. Epidemiološko spremljanje nalezljivih bolezni v Sloveniji v letu 2012. https://www.nijz.si/sites/www.nijz.si/files/publikacije-datoteke/epidemilosko_spremljanje_nalezljivih_bolezni_2012.pdf. Accessed 17 Oct 2022.

  13. NIJZ. Po dolgih letih zaznali primer tetanus pri otroku. https://www.nijz.si/sl/po-dolgih-letih-zaznali-primer-tetanusa-pri-otroku. Accessed 17 Oct 2022.

  14. WHO. Immunization, vaccines and biologicals. Tetanus. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/tetanus. Accessed 17 Oct 2022.

  15. Program cepljenja in zaščite z zdravili za leto 2022. https://e-uprava.gov.si/.download/edemokracija/datotekaVsebina/533863?disposition=inline. Accessed 17 Oct 2022.

  16. NIJZ. Navodila in priporočila za cepljenje. Profilaksa tetanusa po poškodbi. https://www.nijz.si/sl/navodila-in-priporocila-za-cepljenje-0#profilaksa-tetanusa-po-poskodbi. Accessed 17 Oct 2022.

  17. Médecins Sans Frontières. Clinical guidelines—Diagnosis and treatment manual. Tetanus. https://medicalguidelines.msf.org/en/viewport/CG/english/tetanus-16689919.html?language_content_entity=en. Accessed 17 Oct 2022.

  18. CDC. Tetanus for clinicians. https://www.cdc.gov/tetanus/clinicians.html. Accessed 17 Oct 2022.

  19. Ablett score. https://www.researchgate.net/figure/Ablett-Classification-of-Tetanus-Severity_tbl2_50227007. Accessed 17 Oct 2022.

  20. Muzlovič I. Tetanus. In: Tomažič J, Strle F, editors. Infekcijske bolezni. Ljubljana: Združenje za infektologijo, Slovensko zdravniško društvo; 2014. pp. 230–2.

    Google Scholar 

  21. Wienberger B, Keller M, Putzer C, Breitenberger D, Koller B, Fiegl S, et al. Protection against Tetanus and Diphtheria in Europe: the impact of age, gender and country of origin based on data from the MARK-AGE Study. Exp Gerontol. 2018;105:109–12.

    Article  Google Scholar 

  22. Arsić B. Vaccination against typhoid, paratyphoid and tetanus in the Yugoslav National Army. Vojnisanit Pregl. 1967;24(9):4–9. Serbian.

    Google Scholar 

  23. Mahieu R, Reydel T, Maamar A, Tadie JM, Jamet A, Thille AW, et al. Admission of tetanus patients to the ICU: a retrospective multicentric study. Ann Intensive Care. 2017;7:112.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Hellyer TP, Ewan V, Wilson P, Simpson AJ. The intensive care society recommended bundle of interventions for prevention of ventilator-associated pneumonia. J Int Care Soc. 2016;17:238–43.

    Article  Google Scholar 

  25. Rosenthal VD, Bijie H, Maki DG, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004–2009. Am J Infect Control. 2012;40(5):396–407.

    Article  PubMed  Google Scholar 

  26. Suljevic I, Asotic D, Surkovic I, Turan M, Spahovic H. Frequency of ventilator associated pneumonias in patients in intensive care unit. Med Arch. 2022;74:285–8.

    Article  Google Scholar 

  27. Cook TM, Protheroe RT, Handel JM. Tetanus: a review of the literature. Br J Anaesth. 2011;87:477–87.

    Article  Google Scholar 

  28. Duchen LW, Tonge DA. The effects of tetanus toxin on neuromuscular transmission and on the morphology of motor end-plates in slow and fast skeletal muscle of the mouse. J Physiol. 1973;228:157–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Chorath K, Hoang A, Rajasekaran K, Moreira A. Association of early vs late tracheostomy placement with pneumonia and ventilator days in critically ill patients. Jama Otolaryngol Head Neck Surg. 2021;147:1–10.

    Article  PubMed Central  Google Scholar 

  30. Andriolo BNG, Andriolo RB, Saconato H, Atallah AN, Valente O, Cochrane Emergency and Critical Group. Early vs. late tracheostomy for critically ill patients. Cochrane Database Syst Rev. 2015; https://doi.org/10.1002/14651858.CD007271.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Karnad DR, Gupta V. Intensive care management of severe tetanus. Indian J Crit Care Med. 2021;25:S155–S60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Rodrigo C, Fernando D, Rajapakse S. Pharmacological management of tetanus: an evidence-based review. Crit Care. 2014;18(2):217.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Campbell JI, Lam TM, Huynh TL, To SD, Tran TT, Nguyen VM, et al. Microbiologic characterization and antimicrobial susceptibility of C. tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg. 2009;80:827–31.

    Article  PubMed  Google Scholar 

  34. Yen LM, Thwaites CL. Tetanus. Lancet. 2019;393:1657–68.

    Article  CAS  PubMed  Google Scholar 

  35. Shah B. A review on pharmacological management of Generalised tetanus. Gen Med. 2018;6:311.

    Article  Google Scholar 

  36. Thwaites CL, Yen LM, Glover C, Tuan PQ, Nga NT, Parry J, et al. Predicting the clinical outcome of tetanus: the tetanus severity score. Trop Med Int Health. 2006;11:279–87.

    Article  CAS  PubMed  Google Scholar 

  37. Davies-Foote R, Trung TN, Duoc NVT, Duc DH, Nhat PTH, Trang VTN, et al. Risk factors associated with mechanical ventilation, autonomic nervous dysfunction and physical outcome in Vietnamese adults with tetanus. Trop Med Health. 2021;49:50. https://doi.org/10.1186/s41182-021-00336-w.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Armitage P, Clifford R. Prognosis in tetanus: Use of data from therapeutic trials. J Infect Dis. 1978;138:1–8.

    Article  CAS  PubMed  Google Scholar 

  39. Sharma N, Li S, Sravanthi MV, Kazmierski D, Wang Y, Sharma A, et al. Tetanus complicated by dysautonomia: a case report and review and management. Case Rep Crit Care. 2021; https://doi.org/10.1155/2021/8842522.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Araki T, Iwanami N, Yamazaki Y. Severe tetanus complicated by Takotsubo cardiomyopathy. Intern Med. 2019;58:2107–12.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Blake PA, Feldman RA, Buchanan TM, Brooks GF, Bennet JV. Serologic therapy of tetanus in United States. JAMA. 1976;235:42–4.

    Article  CAS  PubMed  Google Scholar 

  42. Pisani L, Alegra AG, Neto AS, Azevedo L, Pham T, Paulus F, et al. Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies. Lancet Glob Health. 2022;10:e227–e35.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nina Grasselli Kmet MD, PhD.

Ethics declarations

Conflict of interest

N. Grasselli Kmet, I. Muzlovič, Ž. Martinčič, D. Štubljar and M. Jereb declare that they have no competing interests.

Ethical standards

The study was approved by the National Medical Ethics Committee of the Republic of Slovenia on 11 October 2022 (consent number 0120-556/2018/12).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grasselli Kmet, N., Muzlovič, I., Martinčič, Ž. et al. Adult patients with tetanus in Slovenia 2006–2021. Wien Klin Wochenschr 135, 625–630 (2023). https://doi.org/10.1007/s00508-023-02222-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00508-023-02222-3

Keywords

Navigation